Zolbetuximab

7 trials 2 recruiting LOncology Orphan designation

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

2 Recruiting

5 Completed trials

3 Sponsors

14 Countries

Phase III

Phase II

Phase III: 4 Phase II: 3

Indications tested

Adenocarcinoma gastric 3 Metastatic gastric cancer 2 Gastric cancer 1

Sponsors using this IMP

Astellas Pharma Global Development Inc. 5 Karolinska University Hospital 1 UZ Leuven 1

All trials

7 total

The IPa-Gastric trial: Comparing Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Therapy alone in Gastric Cancer Patients wi… Recruiting

2024-514879-17-00 Phase III 4 countries Karolinska University Hospital
Phase II RAINSPOT: a multicentric open label trial of Zolbetuximab-Paclitaxel-Ramucirumab in second line setting for CLDN18.2 positive gast… Recruiting

2025-521358-41-00 Phase II 1 country UZ Leuven
A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Ended

2024-519773-19-00 Phase III 11 countries Astellas Pharma Global Development Inc.
A Study of Zolbetuximab (IMAB362) in Adults with Pancreatic Cancer Ended

2024-510985-17-00 Phase II 4 countries Astellas Pharma Global Development Inc.
A Study of Zolbetuximab (IMAB362) plus CAPOX in Adults with Gastric Cancer. Ended

2024-511648-16-00 Phase III 3 countries Astellas Pharma Global Development Inc.
A Phase 3, Global, Multi-Center, Double-Blind, Randomized, Efficacy Study of Zolbetuximab (IMAB362) Plus mFOLFOX6 Compared with Placebo Plus… Ended

2024-511365-11-00 Phase III 6 countries Astellas Pharma Global Development Inc.
A Phase 2 Study of Zolbetuximab (IMAB362) as Monotherapy and in Combination with Chemotherapy and/or Immunotherapy in Subjects with Metastat… Ended

2024-511649-21-00 Phase II 2 countries Astellas Pharma Global Development Inc.

Showing 1–7 of 7 trials

← All drugs A–Z